In the realm of molecular biology and protein biochemistry, achieving precise, site-specific modification is a cornerstone of experimental success. One of the most elegant tools for this purpose is the BirA acceptor peptide sequence. Through my personal experience working with enzymatic labeling systems, I have found that understanding the nuances of these tags is essential for anyone looking to achieve consistent results in their workflows.
The Foundatio Plasmids 101: Biotinylation n: What is the BirA Acceptor Peptide?
The process revolves by Y Li·2012·Cited by 120—BirA is the Escherichia coli biotin ligase that site-specifically biotinylates a lysine side chain within a15-amino acid acceptor peptide(also known as Avi- Read more around the *E. coli* biotin ligase, known as BirA. This enzyme acts as a biotin--[biotin carboxyl-carrier protein] ligase, which naturally functions to attach biotin to a specific lysine residue within the biotin carboxyl-carrier protein (BCCP).
Researchers have successfully minimized this natural recognition motif into a short amino acid sequence that can be fused to a protein of interest. This acceptor peptide—often referred to as the AviTag—is a 15-amino acid acceptor peptide (GLNDIFEAQKIEWHE). While early research identified by I Chen·2007—E. coli biotin ligase (BirA) catalyzes the site-specific ligation of biotin to the lysine within its 15-amino acid peptidesubstrate (AP).Read more the 13 amino acid sequence as the minimum requirement for recognition, the extended 15-mer is now the standard for high-efficiency labeling.
Why Use a BirA Acceptor Peptide?
When I first transitioned from chemical labeling to enzymatic methods, the difference in specificity was striking. Chemical biotinylation can often result in multiple biotin molecules attached to various surface lysines, which can interfere with protein function. In contrast, Biotin ligase (BirA) ligates biotin specifically to a biotin acce Method for sequence specific biotinylation ptor peptide, ensuring that the amino acid modification occurs at exactly one residue.
Key takeaways from my trials include:
* Precision: Because BirA adds d-biotin covalently to biotin-acceptor peptides at a single site, you avoid the heterogeneity associated with non-specific chemical reactions.
* Versatility: The acceptor peptide can be placed at the N- or C-terminus, or even internally, provided the protein structure allows for it.
* Efficiency: Using an optimized peptide sequence allows for high-throughput applications, which is vital when screening multiple constructs.
Technical In vivo biotinylation of the major histocompatibility complex Considerations for Implementation
When working with this system, the sequence composition of the tag is critical. The central lysine within the amino-acid peptide is the target. If you are designing your own fusion proteins, ensure that the flanking regions do not create steric hindrance that might block the enzyme's access.
I have observed that the performance of this peptide can be influenced by the expression host. Whether you are expressing in *E. coli* or mammalian systems, the BirA enzyme must be present in sufficient concentration to catalyze the reaction. Some protocols involve co-expression of the ligase, while others utilize purified enzyme for *in vitro* labeling.
Practical Tips for Success
1. Sequence Integrity: Always verify your amino acid sequence after cloning. Given that the 13 amino acid sequence is the core, even a single point mutation can abolish the recognition by the enzyme.
2. Buffer Optimization: The BirA enzyme requires ATP and biotin in the reaction buffer. I recommend testing different concentrations to ensure the biotin-acceptor peptide is fully labeled.
3. Entity Awareness: Remember that several peptide sequences have been described for BirA-mediated biotinylation. While the AviTag is the most common, always check the literature if you are working with non-standard variants.
4. Verification: Use a simple pull-down assay or Western blot with streptavidin-HRP to confirm that your acceptor peptide has been successfully biotinylated.
By focusing on the BirA recognition motif and ensuring the peptide sequence is correctly incorporated i Library‐on‐Library Intercellular Labeling for Selection of Biotin nto your protein construct, you can achieve highly re by I Chen·2007—E. coli biotin ligase (BirA) catalyzes the site-specific ligation of biotin to the lysine within its 15-amino acid peptidesubstrate (AP).Read more producible labeling. This method remains one of the most reliable ways to handle protein tags, providing a clean, site-specific result every time.